Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein.

Xie Q, Wang Z, Ni F, Chen X, Ma J, Patel N, Lu H, Liu Y, Tian JH, Flyer D, Massare MJ, Ellingsworth L, Glenn G, Smith G, Wang Q.

PLoS One. 2019 Feb 7;14(2):e0210749. doi: 10.1371/journal.pone.0210749. eCollection 2019.

2.

Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.

Gilbert BE, Patel N, Lu H, Liu Y, Guebre-Xabier M, Piedra PA, Glenn G, Ellingsworth L, Smith G.

Vaccine. 2018 Dec 18;36(52):8069-8078. doi: 10.1016/j.vaccine.2018.10.073. Epub 2018 Oct 30.

PMID:
30389195
3.

Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge.

Liu Y, Ye L, Lin F, Gomaa Y, Flyer D, Carrion R Jr, Patterson JL, Prausnitz MR, Smith G, Glenn G, Wu H, Compans RW, Yang C.

Sci Rep. 2018 Jul 25;8(1):11193. doi: 10.1038/s41598-018-29135-w.

4.

Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate.

Luke T, Bennett RS, Gerhardt DM, Burdette T, Postnikova E, Mazur S, Honko AN, Oberlander N, Byrum R, Ragland D, St Claire M, Janosko KB, Smith G, Glenn G, Hooper J, Dye J, Pal S, Bishop-Lilly KA, Hamilton T, Frey K, Bollinger L, Wada J, Wu H, Jiao JA, Olinger GG, Gunn B, Alter G, Khurana S, Hensley LE, Sullivan E, Jahrling PB.

J Infect Dis. 2018 Nov 22;218(suppl_5):S636-S648. doi: 10.1093/infdis/jiy377.

5.

Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine.

Shinde V, Fries L, Wu Y, Agrawal S, Cho I, Thomas DN, Spindler M, Lindner E, Hahn T, Plested J, Flyer D, Massare MJ, Zhou B, Fix A, Smith G, Glenn GM.

N Engl J Med. 2018 Jun 14;378(24):2346-2348. doi: 10.1056/NEJMc1803554. No abstract available.

6.

Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge.

Liu Y, Ye L, Lin F, Gomaa Y, Flyer D, Carrion R Jr, Patterson JL, Prausnitz MR, Smith G, Glenn G, Wu H, Compans RW, Yang C.

J Infect Dis. 2018 Nov 22;218(suppl_5):S545-S552. doi: 10.1093/infdis/jiy267.

PMID:
29893888
7.

The Vari-Simplex Discipline.

Glenn G.

J Clin Orthod. 2017 Sep;51(9):532-535. No abstract available.

PMID:
29130909
8.

Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.

Smith G, Liu Y, Flyer D, Massare MJ, Zhou B, Patel N, Ellingsworth L, Lewis M, Cummings JF, Glenn G.

Vaccine. 2017 Sep 25;35(40):5366-5372. doi: 10.1016/j.vaccine.2017.08.021. Epub 2017 Aug 22.

9.

Solution blow spun nanocomposites of poly(lactic acid)/cellulose nanocrystals from Eucalyptus kraft pulp.

Parize DDDS, Oliveira JE, Williams T, Wood D, Avena-Bustillos RJ, Klamczynski AP, Glenn GM, Marconcini JM, Mattoso LHC.

Carbohydr Polym. 2017 Oct 15;174:923-932. doi: 10.1016/j.carbpol.2017.07.019. Epub 2017 Jul 10.

PMID:
28821149
10.

Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.

Tian JH, Glenn G, Flyer D, Zhou B, Liu Y, Sullivan E, Wu H, Cummings JF, Elllingsworth L, Smith G.

Vaccine. 2017 Jul 24;35(33):4079-4087. doi: 10.1016/j.vaccine.2017.06.062. Epub 2017 Jun 29.

11.

Structural plasticity of the ventral stream and aphasia recovery.

McKinnon ET, Fridriksson J, Glenn GR, Jensen JH, Helpern JA, Basilakos A, Rorden C, Shih AY, Spampinato MV, Bonilha L.

Ann Neurol. 2017 Jul;82(1):147-151. doi: 10.1002/ana.24983.

12.

Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.

Smith GE, Sun X, Bai Y, Liu YV, Massare MJ, Pearce MB, Belser JA, Maines TR, Creager HM, Glenn GM, Flyer D, Pushko P, Levine MZ, Tumpey TM.

Virology. 2017 Sep;509:90-97. doi: 10.1016/j.virol.2017.06.006. Epub 2017 Jun 16.

13.

A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.

August A, Glenn GM, Kpamegan E, Hickman SP, Jani D, Lu H, Thomas DN, Wen J, Piedra PA, Fries LF.

Vaccine. 2017 Jun 27;35(30):3749-3759. doi: 10.1016/j.vaccine.2017.05.045. Epub 2017 Jun 1.

14.

Solution Blow Spinning of Food-Grade Gelatin Nanofibers.

Liu F, Avena-Bustillos RJ, Bilbao-Sainz C, Woods R, Chiou BS, Wood D, Williams T, Yokoyama W, Glenn GM, McHugh TH, Zhong F.

J Food Sci. 2017 Jun;82(6):1402-1411. doi: 10.1111/1750-3841.13710. Epub 2017 May 4.

PMID:
28471491
15.

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults.

Fries L, Shinde V, Stoddard JJ, Thomas DN, Kpamegan E, Lu H, Smith G, Hickman SP, Piedra P, Glenn GM.

Immun Ageing. 2017 Apr 12;14:8. doi: 10.1186/s12979-017-0090-7. eCollection 2017.

16.

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.

Coleman CM, Venkataraman T, Liu YV, Glenn GM, Smith GE, Flyer DC, Frieman MB.

Vaccine. 2017 Mar 14;35(12):1586-1589. doi: 10.1016/j.vaccine.2017.02.012. Epub 2017 Feb 23.

17.

Evaluating kurtosis-based diffusion MRI tissue models for white matter with fiber ball imaging.

Jensen JH, McKinnon ET, Glenn GR, Helpern JA.

NMR Biomed. 2017 May;30(5). doi: 10.1002/nbm.3689. Epub 2017 Jan 13.

18.

Preoperative automated fibre quantification predicts postoperative seizure outcome in temporal lobe epilepsy.

Keller SS, Glenn GR, Weber B, Kreilkamp BA, Jensen JH, Helpern JA, Wagner J, Barker GJ, Richardson MP, Bonilha L.

Brain. 2017 Jan;140(1):68-82. doi: 10.1093/brain/aww280. Epub 2016 Nov 15.

19.

Dependence on b-value of the direction-averaged diffusion-weighted imaging signal in brain.

McKinnon ET, Jensen JH, Glenn GR, Helpern JA.

Magn Reson Imaging. 2017 Feb;36:121-127. doi: 10.1016/j.mri.2016.10.026. Epub 2016 Oct 27.

20.

Preparation of Zein Fibers Using Solution Blow Spinning Method.

Liu F, Avena-Bustillos RJ, Woods R, Chiou BS, Williams TG, Wood DF, Bilbao-Sainz C, Yokoyama W, Glenn GM, McHugh TH, Zhong F.

J Food Sci. 2016 Dec;81(12):N3015-N3025. doi: 10.1111/1750-3841.13537. Epub 2016 Nov 9.

PMID:
27861896
21.

Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle.

Dye JM, Wu H, Hooper JW, Khurana S, Kuehne AI, Coyle EM, Ortiz RA, Fuentes S, Herbert AS, Golding H, Bakken RA, Brannan JM, Kwilas SA, Sullivan EJ, Luke TC, Smith G, Glenn G, Li W, Ye L, Yang C, Compans RW, Tripp RA, Jiao JA.

Sci Rep. 2016 Apr 25;6:24897. doi: 10.1038/srep24897.

22.

Epilepsy-related cytoarchitectonic abnormalities along white matter pathways.

Glenn GR, Jensen JH, Helpern JA, Spampinato MV, Kuzniecky R, Keller SS, Bonilha L.

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):930-6. doi: 10.1136/jnnp-2015-312980. Epub 2016 Apr 13.

PMID:
27076491
23.

Mapping the Orientation of White Matter Fiber Bundles: A Comparative Study of Diffusion Tensor Imaging, Diffusional Kurtosis Imaging, and Diffusion Spectrum Imaging.

Glenn GR, Kuo LW, Chao YP, Lee CY, Helpern JA, Jensen JH.

AJNR Am J Neuroradiol. 2016 Jul;37(7):1216-22. doi: 10.3174/ajnr.A4714. Epub 2016 Mar 3.

24.

Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.

Bengtsson KL, Song H, Stertman L, Liu Y, Flyer DC, Massare MJ, Xu RH, Zhou B, Lu H, Kwilas SA, Hahn TJ, Kpamegan E, Hooper J, Carrion R Jr, Glenn G, Smith G.

Vaccine. 2016 Apr 7;34(16):1927-35. doi: 10.1016/j.vaccine.2016.02.033. Epub 2016 Feb 24.

25.

Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.

Luke T, Wu H, Zhao J, Channappanavar R, Coleman CM, Jiao JA, Matsushita H, Liu Y, Postnikova EN, Ork BL, Glenn G, Flyer D, Defang G, Raviprakash K, Kochel T, Wang J, Nie W, Smith G, Hensley LE, Olinger GG, Kuhn JH, Holbrook MR, Johnson RF, Perlman S, Sullivan E, Frieman MB.

Sci Transl Med. 2016 Feb 17;8(326):326ra21. doi: 10.1126/scitranslmed.aaf1061.

PMID:
26888429
26.

Controlled Release of Linalool Using Nanofibrous Membranes of Poly(lactic acid) Obtained by Electrospinning and Solution Blow Spinning: A Comparative Study.

Souza MA, Oliveira JE, Medeiros ES, Glenn GM, Mattoso LH.

J Nanosci Nanotechnol. 2015 Aug;15(8):5628-36.

PMID:
26369129
27.

Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs.

Glenn GM, Fries LF, Smith G, Kpamegan E, Lu H, Guebre-Xabier M, Hickman SP, Flyer D.

Vaccine. 2015 Nov 25;33(47):6488-92. doi: 10.1016/j.vaccine.2015.08.039. Epub 2015 Aug 28.

28.

Optimization of white matter fiber tractography with diffusional kurtosis imaging.

Glenn GR, Helpern JA, Tabesh A, Jensen JH.

NMR Biomed. 2015 Oct;28(10):1245-56. doi: 10.1002/nbm.3374. Epub 2015 Aug 14.

PMID:
26275886
29.

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.

Glenn GM, Fries LF, Thomas DN, Smith G, Kpamegan E, Lu H, Flyer D, Jani D, Hickman SP, Piedra PA.

J Infect Dis. 2016 Feb 1;213(3):411-22. doi: 10.1093/infdis/jiv406. Epub 2015 Aug 10.

PMID:
26259809
30.

ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans.

Chung KY, Coyle EM, Jani D, King LR, Bhardwaj R, Fries L, Smith G, Glenn G, Golding H, Khurana S.

Vaccine. 2015 Jul 31;33(32):3953-62. doi: 10.1016/j.vaccine.2015.06.047. Epub 2015 Jun 17.

PMID:
26093202
31.

CT Evaluation of Small-Diameter Coronary Artery Stents: Effect of an Integrated Circuit Detector with Iterative Reconstruction.

Geyer LL, Glenn GR, De Cecco CN, Van Horn M, Canstein C, Silverman JR, Krazinski AW, Kemper JM, Bucher A, Ebersberger U, Costello P, Bamberg F, Schoepf UJ.

Radiology. 2015 Sep;276(3):706-14. doi: 10.1148/radiol.15140427. Epub 2015 Mar 17.

PMID:
25786157
32.

Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.

Liu YV, Massare MJ, Pearce MB, Sun X, Belser JA, Maines TR, Creager HM, Glenn GM, Pushko P, Smith GE, Tumpey TM.

Vaccine. 2015 Apr 27;33(18):2152-8. doi: 10.1016/j.vaccine.2015.03.009. Epub 2015 Mar 13.

33.

Caregiver tele-support group for Parkinson's disease: A pilot study.

Shah SP, Glenn GL, Hummel EM, Hamilton JM, Martine RR, Duda JE, Wilkinson JR.

Geriatr Nurs. 2015 May-Jun;36(3):207-11. doi: 10.1016/j.gerinurse.2015.02.002. Epub 2015 Mar 3.

PMID:
25744558
34.

Quantitative assessment of diffusional kurtosis anisotropy.

Glenn GR, Helpern JA, Tabesh A, Jensen JH.

NMR Biomed. 2015 Apr;28(4):448-59. doi: 10.1002/nbm.3271. Epub 2015 Feb 26.

35.

In vitro antimicrobial activity of solution blow spun poly(lactic acid)/polyvinylpyrrolidone nanofibers loaded with Copaiba (Copaifera sp.) oil.

Bonan RF, Bonan PR, Batista AU, Sampaio FC, Albuquerque AJ, Moraes MC, Mattoso LH, Glenn GM, Medeiros ES, Oliveira JE.

Mater Sci Eng C Mater Biol Appl. 2015 Mar;48:372-7. doi: 10.1016/j.msec.2014.12.021. Epub 2014 Dec 9.

PMID:
25579936
36.

Torrefaction of pomaces and nut shells.

Chiou BS, Valenzuela-Medina D, Bilbao-Sainz C, Klamczynski AK, Avena-Bustillos RJ, Milczarek RR, Du WX, Glenn GM, Orts WJ.

Bioresour Technol. 2015 Feb;177:58-65. doi: 10.1016/j.biortech.2014.11.071. Epub 2014 Nov 20.

PMID:
25479394
37.

Maternal immunization: opportunities for scientific advancement.

Beigi RH, Fortner KB, Munoz FM, Roberts J, Gordon JL, Han HH, Glenn G, Dormitzer PR, Gu XX, Read JS, Edwards K, Patel SM, Swamy GK.

Clin Infect Dis. 2014 Dec 15;59 Suppl 7:S408-14. doi: 10.1093/cid/ciu708.

38.

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization.

Raghunandan R, Lu H, Zhou B, Xabier MG, Massare MJ, Flyer DC, Fries LF, Smith GE, Glenn GM.

Vaccine. 2014 Nov 12;32(48):6485-92. doi: 10.1016/j.vaccine.2014.09.030. Epub 2014 Sep 28.

39.

A simple noise correction scheme for diffusional kurtosis imaging.

Glenn GR, Tabesh A, Jensen JH.

Magn Reson Imaging. 2015 Jan;33(1):124-33. doi: 10.1016/j.mri.2014.08.028. Epub 2014 Aug 28.

40.

Orthodontists encourage use of mouth guards for all contact sports.

Glenn G.

N J Nurse. 2014 Jul;44(3):8. No abstract available.

PMID:
25007504
41.

Identification and mutagenesis of the TACE and γ-secretase cleavage sites in the colony-stimulating factor 1 receptor.

Vahidi A, Glenn G, van der Geer P.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):782-7. doi: 10.1016/j.bbrc.2014.06.061. Epub 2014 Jun 21.

PMID:
24955855
42.

Preparation of protein samples for mass spectrometry and N-terminal sequencing.

Glenn G.

Methods Enzymol. 2014;536:27-44. doi: 10.1016/B978-0-12-420070-8.00003-9.

PMID:
24423264
43.

Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.

Behrens RH, Cramer JP, Jelinek T, Shaw H, von Sonnenburg F, Wilbraham D, Weinke T, Bell DJ, Asturias E, Pauwells HL, Maxwell R, Paredes-Paredes M, Glenn GM, Dewasthaly S, Stablein DM, Jiang ZD, DuPont HL.

Lancet Infect Dis. 2014 Mar;14(3):197-204. doi: 10.1016/S1473-3099(13)70297-4. Epub 2013 Nov 29.

PMID:
24291168
44.

A recombinant viruslike particle influenza A (H7N9) vaccine.

Fries LF, Smith GE, Glenn GM.

N Engl J Med. 2013 Dec 26;369(26):2564-6. doi: 10.1056/NEJMc1313186. Epub 2013 Nov 13. No abstract available.

45.

Analysis of DNA by Southern blotting.

Glenn G, Andreou LV.

Methods Enzymol. 2013;529:47-63. doi: 10.1016/B978-0-12-418687-3.00005-7.

PMID:
24011036
46.

Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.

Smith GE, Flyer DC, Raghunandan R, Liu Y, Wei Z, Wu Y, Kpamegan E, Courbron D, Fries LF 3rd, Glenn GM.

Vaccine. 2013 Sep 13;31(40):4305-13. doi: 10.1016/j.vaccine.2013.07.043. Epub 2013 Jul 26.

47.

Cutaneous vaccination: antigen delivery into or onto the skin.

Weniger BG, Glenn GM.

Vaccine. 2013 Jul 25;31(34):3389-91. doi: 10.1016/j.vaccine.2013.05.048. Epub 2013 May 16. No abstract available.

PMID:
23684830
48.

Brucite nanoplates reinforced starch bionanocomposites.

Moreira FK, Pedro DC, Glenn GM, Marconcini JM, Mattoso LH.

Carbohydr Polym. 2013 Feb 15;92(2):1743-51. doi: 10.1016/j.carbpol.2012.11.019. Epub 2012 Nov 14.

PMID:
23399215
49.

Solid lipid particles in lipid films to control the diffusive release of 2-heptanone.

Bilbao-Sáinz C, Chiou BS, Glenn GM, Gregorsky KS, Williams TG, Wood DF, Klamczynski AP, Orts WJ.

Pest Manag Sci. 2013 Aug;69(8):975-82. doi: 10.1002/ps.3462. Epub 2013 Jan 28.

PMID:
23355371
50.

Properties of electrospun pollock gelatin/poly(vinyl alcohol) and pollock gelatin/poly(lactic acid) fibers.

Chiou BS, Jafri H, Avena-Bustillos R, Gregorski KS, Bechtel PJ, Imam SH, Glenn GM, Orts WJ.

Int J Biol Macromol. 2013 Apr;55:214-20. doi: 10.1016/j.ijbiomac.2013.01.010. Epub 2013 Jan 23.

PMID:
23352992

Supplemental Content

Support Center